1. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990;6:11-15.
2.
2. Massie MJ, Holland J, Glass E. Delirium in terminally ill cancer patients. AmJPsychiatry. 1983;140:1048-1050.
3.
3. Back IN. Terminal restlessness in patients with advanced malignant disease. Palliat Med. 1992;6:293-298.
4.
4. Mercadante S, De Conno F, Ripamonti C. Propofol in terminal care. J Pain Symptom Manage. 1995;10:639-642.
5.
5. Sebel PS, LowdonJD. Propofol: a new intravenous anesthetic agent. Anesthesiology. 1989;71:260-277.
6.
6. Morton NS, Johnston G, White M, Marsh BJ. Propofol in paediatric anaesthesia. Paediatric Anaesthesia. 1992;2:89-97.
7.
7. MoyleJ. The use of propofol in palliative medicine. JPain Symptom Manage. 1995;10:643-646.
8.
8. McNamara P, Minto M, Twycriss RG. Use of midazolam in palliative care. Palliat Med. 1991;5:244-249.
9.
9. Foy A, Drinkwater V, March S, Mearrick P. Confusion after admission to hospital in elderly patients using benzodiazepines. BrMedj1986;293:1072-1072.
10.
10. Raftery S, Sherry E. Total intravenous anesthesia with propofol and alfentanil protects against nausea and vomiting. Can JAnaesth. 1993;5:268-274.
11.
11. Brussel T, TheissenJL, Vigfusson G, et al. Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol. Anesth Analg. 1989;69:3540-3540.
12.
12. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic propofol. N Engl JMed. 1995;333:147-154.